1. "2008"
Formats
  1. Journal Article (1794)
  2. Meeting Abstract (728)
  3. Book Section (244)
  4. Conference Paper (25)
  5. Book Whole (18)
Groups
  1. Department of Medicine (779)
  2. Surgery (721)
  3. GSK Faculty (507)
  4. Sloan Kettering Institute Faculty (471)
  5. Solid Tumor Oncology Division (455)
  6. Survivorship Research (381)

More Groups

People
  1. David Klimstra (60)
  2. Yuman Fong (56)
  3. Nadeem Abu-Rustum (55)
  4. Peter Scardino (52)
  5. Robert Soslow (52)
  6. Dennis Chi (51)

More People

Years
  1. 2008 (2809)
Publications
  1. Journal of Clinical Oncology (228)
  2. Blood (83)
  3. International Journal of Radiation Oncology, Biology, Physics (71)
  4. Modern Pathology (65)
  5. Cancer Research (59)
  6. Gynecologic Oncology (59)

More Publications

Publishers
  1. Elsevier Inc. (340)
  2. American Society of Clinical Oncology (230)
  3. Lippincott Williams & Wilkins (164)
  4. Nature Publishing Group (150)
  5. Springer (143)
  6. Elsevier Science, Inc. (131)

More Publishers

Results (2809)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Peripheral-blood gene expression profiling in bladder cancer (BC) patients (pts)
    Meeting Abstract

    Apolo, A. B.; Osman, I.; Shen, R.; Olshen, A. B.; Bajorin, D. F.
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • HDM2 overexpression and promoter polymorphism (SNP309) genotype: Comparison between African American (AA) and Caucasian American (CA) prostate cancer patients (pts)
    Meeting Abstract

    Wang, G.; Blochin, E.; Christos, P.; Pollens, D.; Yu, J. Z.; Mazumdar, M.; Gerald, W.; Lee, P.; Oddoux, C.; Osman, I.
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • Trends in Memorial Sloan-Kettering Cancer Center risk group distribution according to treatment year for patients with metastatic renal cell carcinoma (mRCC)
    Meeting Abstract

    Patil, S.; Ishill, N. M.; Deluca, J.; Motzer, R. J.
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • Survival rates after resection for localized kidney cancer: 1989-2004
    Meeting Abstract

    Jang, T. L.; Pettus, J. A.; Huang, W. C.; Eggener, S. E.; O'Brien, M. F.; Karellas, M. E.; Kagiwada, M. A.; Russo, P.
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • A phase I study of oral panobinostat (LBH589) alone and in combination with docetaxel (Doc) and prednisone in castration-resistant prostate cancer (CRPC)
    Meeting Abstract

    Rathkopf, D. E.; Wong, B. Y.; Ross, R. W.; George, D. J.; Picus, J.; Tanaka, E.; Chen, Y.; Atadja, P.; Yang, W.; Culver, K. W.; more...
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • Outcome prediction in adult male germ cell tumor patients through expression profiling
    Meeting Abstract

    Korkola, J.; Houldsworth, J.; Feldman, D. R.; Olshen, A. B.; Qin, L.; Patil, S.; Reuter, V. E.; Bosl, G. J.; Chaganti, R. S.
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • Pancreatic adenocarcinoma (PAC) in a younger patient population: 10-year experience at Memorial Sloan-Kettering Cancer Center (MSKCC)
    Meeting Abstract

    Duffy, A.; Capanu, M.; Allen, P.; Kurtz, R.; Ludwig, E.; Olson, S.; Klimstra, D.; Abou-Alfa, G. K.; Kelsen, D. P.; O'Reilly, E. M.
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • Phase I study of docetaxel (Tax) and (153)Sm repetitively administered for castrate metastatic prostate cancer (CMPC)
    Meeting Abstract

    Morris, M. J.; Pandit-Taskar, N.; Stephenson, R. D.; Hong, C.; Slovin, S. F.; Solit, D.; Rathkopf, D. E.; Carrasquillo, J. A.; Larson, S. M.; Scher, H. I.
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • Expression of the c-met and HGF in resected hepatocellular carcinoma (rHCC): Correlation with clinicopathological features (CP) and overall survival (OS)
    Meeting Abstract

    Huitzil, F. D.; Sun, M. Y.; Capanu, M.; Blumgart, L. H.; Jarnagin, W. R.; Fong, Y.; DeMatteo, R. P.; D'Angelica, M. I.; Weiser, M. R.; Abou-Alfa, G. K.
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • Phase I trial of ipilimumab (IPI) alone and in combination with radiotherapy (XRT) in patients with metastatic castration resistant prostate cancer (mCRPC)
    Meeting Abstract

    Beer, T. M.; Slovin, S. F.; Higano, C. S.; Tejwani, S.; Dorff, T. B.; Stankevich, E.; Lowy, I.; Prostate Cancer Clinical Trials Consortium
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save